Search

everythinglearnresearchcommunity

for

Search:↓

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

A new engineered treatment shows promise in curing heart fibrosis.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

A nurse-led hair service reduced waiting times and improved patient satisfaction and outcomes for alopecia areata treatment.

The T-Fast multi-implanter makes hair transplant surgeries quicker and cheaper.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

BFNB could be a promising treatment for hair growth.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Large-scale fibronectin nanofibers help heal wounds and repair tissue in a skin model of a mouse.

Darkened knuckles can be an early sign of insulin resistance.

The formulated gel is a promising treatment for alopecia areata.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

The ferret had a malignant apocrine gland tumor and did not survive surgery.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.